Prevalência de COVID-19 em gestantes no Rio Grande do Sul

Abstract

Introduction: The SARS-CoV-2 virus, from the coronavirus family, was responsible in March 2020 for triggering a pandemic in just over three months of its indications in Wuhan, China. The pathology can affect the entire population, however some groups were considered at risk, including women in pregnancy. Objective: Based on the importance of the consequences of COVID-19 in pregnancy, it became urgent to estimate the prevalence of this pathology in pregnant women in the state of Rio Grande do Sul. In order to assess the epidemiological profile, allocate targeted treatment and pay attention to possible difficulties presented during the gestational period when this phase is affected by COVID-19. Method: Pregnant patients who acquired COVID-19 in the state of Rio Grande do Sul from March 2020 to December 2021 were analyzed on the government platform Panel Coronavirus RS, website http: //SES/RS - Coronavirus (saude.rs) .gov.br). Data were tabulated directly from the coronavirus panel platform and were extracted and analyzed in LibreOffice version 7.1.0 (free distribution). Results: A sample of 7443 pregnant women was obtained, with a prevalence of 2.8% of cases of COVID-19. White pregnant women, ethnicity unspecified and brown aged between 20 and 29 and 30 to 39 years old were the most affected by the disease. The RT-PCR and rapid tests were the most used as diagnostic tools, respectively. The most expressive numbers of cases occurred in the health macro-regions Metropolitana, Norte and Serra. Of the pregnant women who were infected by the virus, 10.7% needed to be hospitalized and 1% died. It was also observed that the age group from 20 to 39 years old, white, hospitalized, who presented symptoms such as fever, cough, sore throat and dyspnea had a statistically significant relationship with the death outcome. Conclusion: In this sample under analysis, it was possible to highlight the significant prevalence of the disease and the specified epidemiological and sociodemographic profile of pregnant women related to COVID-19. In addition, attention must be paid to the expressive rate of hospitalization with the outcome of death in white women, aged between 20 and 39 years, with signs and symptoms characteristic of respiratory disease.